{"name":"Nkarta, Inc.","slug":"nkarta-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"NKX101 - CAR NK cell therapy","genericName":"NKX101 - CAR NK cell therapy","slug":"nkx101-car-nk-cell-therapy","indication":"Other","status":"phase_1"},{"name":"NKX019","genericName":"NKX019","slug":"nkx019","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"NKX101 - CAR NK cell therapy","genericName":"NKX101 - CAR NK cell therapy","slug":"nkx101-car-nk-cell-therapy","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"NKX019","genericName":"NKX019","slug":"nkx019","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1rSkhhR1MySTdrVUFHSjJmYlVxSk5nOVdaYVo3Z0ZiVndBRFFyaEFfN0ZGTDlSNTNnUnNvdWpWZklmTzlBdEhVWnhZdmRZdTVNa25tV09vZlNVUFFWWXBKeWZiX190MmFhTTdGR0tn?oc=5","date":"2026-04-08","type":"pipeline","source":"Stock Titan","summary":"If You Invested $1,000 in Nkarta, Inc. (NKTX) - Stock Titan","headline":"If You Invested $1,000 in Nkarta, Inc. (NKTX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwJBVV95cUxOdEhIV3lPamJHbFNhMmFsZTJHXzRMTGtHZUs0dV9lRTVQV0VDQmUwVEdDc0hReDZzcDVmLS1ONTRZa2dYWWR6R0V0dW9kd0xkQl9Da3d4T3lDZU9nSFNYTi1KV1MzWTc4WFpPbFJzby0zdDVMenV0dnZoejZDaXZxcGo5LTBpUFFQRVlRMEZXRlBtOENVV1ppSmlZTmYwQldsQUZSSzJWeWFrcW5oeUp3ZkZmanlzZmxKVWlVSWV2WElpNGV3THNfM0xDaW1yM3oteFFEdDVtREVZaElvZE9LR0JhaTkzTi1sVnpCc1hlaW5seXZ1V1FFRW4tQVRMN1NUbzVqU3doYlJjNG1MUm5EaDJ3TDJtLTNqWmNuNzBWZXVMUE16Nzl5STBCWQ?oc=5","date":"2026-04-06","type":"pipeline","source":"GlobeNewswire","summary":"Idiopathic Membranous Nephropathy Market is Predicted to - GlobeNewswire","headline":"Idiopathic Membranous Nephropathy Market is Predicted to","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTFB1N2d4NnYwN0JiU181Tm9vV0dUM1c1NWVMUHNCdlZFVmRSZXpmRFp3TnBQUVJXYnFYV1VlNVBIZXU0TzY4bE5BNTd4NGpIT21aYlZHMy1qSW1HWDFH?oc=5","date":"2026-04-06","type":"pipeline","source":"BioSpace","summary":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees - BioSpace","headline":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxOMy1RWFhOSnE5MFgtSXliWXNFZXpLdWRWYUZsZlZmVldhS19SckR0aGxHZ2ZROUxLVHhJOTd5VWdPb3lUdFhBbFQxbmJHcng2bnZmcFBZVEd1MGdNZVBRczd2T2w1TVhtQnpCRlRMSmZzNks3a3ktOHVNZ0k4QVVhdVV4ZWU1RXpablNweGd3bGN4MjR1dlZGejdPQWRxdjJQMnVzTVNQczZKLUQzNDktNUFqYy1nZC1EU1pSMVdXRFZCTFBmYXdQU2NTbHFsNzRhYTZfelNnajNOaVVPSlUyamdKZFFKRlUwTXdDdlo0WnFPYWROd1lMUGhlZ0NEUC1xbnNabDhhVzMtdzl2R1ZzWVZ2eXphX3Znb3k3Y2FFdw?oc=5","date":"2026-03-27","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Offer Insights on Healthcare Companies: Nkarta (NKTX), QT Imaging Holdings (QTI) and Cardiff Oncology (CRDF) - The Globe and Mail","headline":"Analysts Offer Insights on Healthcare Companies: Nkarta (NKTX), QT Imaging Holdings (QTI) and Cardiff Oncology (CRDF)","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-23","type":"pipeline","source":"simplywall.st","summary":"Nkarta Insiders Make Handsome Sum Selling Stock At US$2.06 Per Share - simplywall.st","headline":"Nkarta Insiders Make Handsome Sum Selling Stock At US$2.06 Per Share","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQSlNvSzd2dUpoSWg2VFgxcllLQmI0X1BKa3JZaXEySUxUNkpmWlA0bHB4Uk5XazlqOW5yNjJickowRHI1UDR5N3JmaEZXZTJOQ1B0Y2ptNFRIem5mb0M0QmVEek9NaDFKNTYwNTRITDZOWWpRbzlsZy0xaktEZXNMVk1HSlJFbVR2eTdUOTFlR2xmc0N4RjJ4TWZFc2duTi1ZaHNBd1FR?oc=5","date":"2025-12-31","type":"pipeline","source":"The Business Journals","summary":"The biggest end-of-year sale in the Bay Area was for $4 billion in biotech stock - The Business Journals","headline":"The biggest end-of-year sale in the Bay Area was for $4 billion in biotech stock","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9iVUFUYkF6aGt3akxZT0hGaW1LLTVITDlQdFFCYUZkc2IwaDJKSHZpQ1d2VmtPWldraV9yWm9idUZab0xqcWZzdXllQ1BIaF9WUGVxcFJMNWhPakFld2QzRVg2dElTbkZjVjdzcEY3QmtFRG96SzhTT25aMkY?oc=5","date":"2025-12-17","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Layoff Tracker 2025: Voyager jettisons 30 staffers; Mythic and Areteia shutter - Fierce Biotech","headline":"Fierce Biotech Layoff Tracker 2025: Voyager jettisons 30 staffers; Mythic and Areteia shutter","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNOTJ0RzJPYWg1X0NxcnFCZE1tREhpNHk3QzJaV0RjS212LVllaFloYmV3cVEtT0p6V0FzWjRha0toSFA5NzU0WjZ6cFA5V19TdENWWWg4OEhmc2tsNzM5WExTdWQ2d1pqNFZPWk94ZFhzOGxVWTFUdk9NUmFiY09LMlM2TVN4WWctQkpDUGNqMWM5TDRuaGhQNzUwV21lbFhJV1k0M2Q2cXZyQTlvdEt1S0VrX3Uta0hwU050R1p6VFA?oc=5","date":"2025-07-23","type":"pipeline","source":"MedCity News","summary":"The Myth of All-American Drugs and What Trump’s Tariffs Miss About Pharma Supply Chains - MedCity News","headline":"The Myth of All-American Drugs and What Trump’s Tariffs Miss About Pharma Supply Chains","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQN2wzNFdHTDNla2x0M19VRTh3U3BPdzBjZGZIcU1XeWxlbnBMRzd4Q1N3U2dzcmNjS0tJMlFOa1N1YkxEWElaZWw4aFNLS2Y3MTY1LWdmUVdSaXdKdmc4cDY3WHNJSzFiSzNHbUx3SkpxUWtyVWYtMDQyUDJqSHVlYjcxb1VrcmVVc3FPXzRrZDc3Rmt0Wkp6cmFsSkwwMGl5U3UzS1k3d1hwZnBU?oc=5","date":"2025-06-27","type":"pipeline","source":"statnews.com","summary":"Proposed cuts could have ‘catastrophic effect,’ 110 biomedical, health sciences industry leaders tell Congress - statnews.com","headline":"Proposed cuts could have ‘catastrophic effect,’ 110 biomedical, health sciences industry leaders tell Congress","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNZ0FabFdQQ2wxX1BZd3lqdnhYUmtDNzY2NXJjYjRFQ0dqa21tMFlqQlN6bGNzZzVuaEdCVlJFT2wxNlVMSHlMS2wza1MtazREb3E5UDRPVU5NdFQ4WjdVeTJlaEJmTW1kSUdYRHNiY2JwZUZsNXZsbG1OeXFuemV2SHBidXJuSFRWTWx4NlFVY09USnFPTC1EellRRQ?oc=5","date":"2025-03-27","type":"pipeline","source":"BioPharma Dive","summary":"Nkarta to lay off staff, senior leadership, in bid to advance autoimmune cell therapy - BioPharma Dive","headline":"Nkarta to lay off staff, senior leadership, in bid to advance autoimmune cell therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxOLTNGclp3R1k1Ql95djVkdTRCRG1mbmlmSDhFTm52MlJGZjdaNG9qU1VfbWxyUUVoOWs3aUJvUUY2M3o4bEtfUExtVXNOY1F0MUU3MzRWbFRSYmZMb0V2eEJuUnNTU1cxQUVFbXZieW1TQmxXRWxuUDRtZlM2allWeUpNQlVvN0gyNHNaSE9CTjQ0TE84ZTJJT0tlSlQtX0FCQWNqMXdhMElMa1lRdDgtZDRRNU84U1otT2ZCbXdEekttb3FKSFNZbnIxRndueUw4S0d4OTR5V3BpNkV0dTNTRzVMM2oxVGxrd1p3TFZCZmNpdXIyZGJkWm1xOW83aDM0UFV2WUM3cTdWOHVrUDg2VHJqcC1YNmxmbWl4VmlhNjlKYkZHMXc?oc=5","date":"2024-11-11","type":"trial","source":"prnewswire.com","summary":"NK Cell Therapy Clinical Trial Pipeline Appears Robust With 140+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - prnewswire.com","headline":"NK Cell Therapy Clinical Trial Pipeline Appears Robust With 140+ Key Pharma Companies Actively Working in the Therapeuti","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE9FTmJ6QmFLdXlBTmxXdjVlcTJIQWJidllHWUV3VEluOU5weDlLcFNTNFJLZGNLZVZQNFNFLVB4aWxaY3hUamRoUHc3OU9DYjBUMDEtbTk4a1NhY2R0UUNnSGRR?oc=5","date":"2024-06-26","type":"pipeline","source":"The Pharma Letter","summary":"Nkarta - The Pharma Letter","headline":"Nkarta","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":2},"enrichmentLevel":0,"visitCount":7,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}